SEI Investments’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

SEI Investments’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-872	Closed	-$18K	–	3036
2018 Q4	$18K	Buy	872 +643	+281%	+$27.9K	﹤0.01%	2508
2018 Q3	$5K	Sell	229 -664	-74%	-$45.4K	﹤0.01%	2457
2018 Q2	$74K	Buy	893 +637	+249%	+$49.2K	﹤0.01%	2381
2018 Q1	$17K	Buy	256 +127	+98%	+$7.33K	﹤0.01%	2708
2017 Q4	$7K	Buy	129 +36	+39%	+$2.59K	﹤0.01%	2898
2017 Q3	$8K	Buy	+93	New	+$7.06K	﹤0.01%	2754
2016 Q4	–	Sell	-120	Closed	-$7K	–	3117
2016 Q3	$7K	Buy	+120	New	+$6.92K	﹤0.01%	2473
2015 Q4	–	Sell	-3,866	Closed	-$161K	–	2779
2015 Q3	$161K	Buy	+3,866	New	+$202K	﹤0.01%	1665

Other funds holding ONCE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

BCM

Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

SEI Investments's ONCE Position: Q1 2019 in Review

SEI Investments sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q1 2019, closing a stake of 872 shares — an estimated $18K sold.

SEI Investments first reported a position in ONCE in Q3 2015 and held it in 8 quarters. The position peaked at $161K in Q3 2015. 199 funds tracked by Wall St. Rank hold ONCE as of Q1 2019.

SEI Investments reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
SEI Investments sold 872 Spark Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $18K.
SEI Investments first reported a position in Spark Therapeutics, Inc. Common Stock in Q3 2015 and held it in 8 quarters.
SEI Investments's Spark Therapeutics, Inc. Common Stock position peaked at $161K in Q3 2015.
199 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q1 2019.

Based on SEI Investments's 13F filing for Q1 2019, filed 15 May 2019.